StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Incyte (INCY) PT Lowered to $92 at RBC Capital Following Earnings
May 4, 2021 12:51 PM
RBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $92.00 (from $93.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Incyte (INCY) Tops Q1 EPS by 4c
May 4, 2021 7:18 AM
Form 8-K INCYTE CORP For: May 04
May 4, 2021 7:09 AM
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
May 4, 2021 7:00 AM
Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021
May 3, 2021 8:00 AM